Fernando C Fervenza, MD - Medicare Nephrology in Rochester, MN

Fernando C Fervenza, MD is a medicare enrolled "Internal Medicine - Nephrology" physician in Rochester, Minnesota. He graduated from medical school in 1982 and has 42 years of diverse experience with area of expertise as Nephrology. He is a member of the group practice Mayo Clinic and his current practice location is 200 1st St Sw, Rochester, Minnesota. You can reach out to his office (for appointments etc.) via phone at (507) 284-2511.

Fernando C Fervenza is licensed to practice in Minnesota (license number 40692) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1356313522.

Contact Information

Fernando C Fervenza, MD
200 1st St Sw,
Rochester, MN 55905-0001
(507) 284-2511
Not Available



Physician's Profile

Full NameFernando C Fervenza
GenderMale
SpecialityNephrology
Experience42 Years
Location200 1st St Sw, Rochester, Minnesota
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Fernando C Fervenza graduated from medical school in 1982
  NPI Data:
  • NPI Number: 1356313522
  • Provider Enumeration Date: 02/02/2006
  • Last Update Date: 08/13/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 6901940618
  • Enrollment ID: I20100218000743

Medical Identifiers

Medical identifiers for Fernando C Fervenza such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1356313522NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RN0300XInternal Medicine - Nephrology 40692 (Minnesota)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Mayo Clinic Hospital RochesterRochester, MNHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Mayo Clinic65077782554232

News Archive

Experimental drug for rare ALS shows promise in early clinical trial

An experimental drug for a rare, inherited form of amyotrophic lateral sclerosis (ALS) has shown promise in a phase 1/phase 2 clinical trial conducted at Washington University School of Medicine in St. Louis, Massachusetts General Hospital in Boston and other sites around the world and sponsored by the pharmaceutical company Biogen Inc.

Evolution of the SARS-CoV-2 proteome in 3D during the first six months of the COVID-19 pandemic

In a recent study, researchers report how the SARS-CoV-2 proteome in 3D has evolved during the first six months of the COVID-19 pandemic.

Drowning deaths rise in Australia

The Royal Life Saving Society, Australia is alarmed at the rise in drownings in waterways around the country. With 314 people dying in a year the figures are at a seven year high. 80% of these were males. The Society noted a 27% rise in the numbers since 2002.

Social stress linked to visceral fat, atherosclerosis

A new study done by researchers at Wake Forest University School of Medicine shows that social stress could be an important precursor to heart disease by causing the body to deposit more fat in the abdominal cavity, speeding the harmful buildup of plaque in blood vessels, a stepping stone to the number one cause of death in the world.

Chromatrap® kit shown to excel in DNA purification

Chromatrap® reports on the excellent results achieved by customers using their 96 well high throughput plates for ultra-pure DNA purification.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Fernando C Fervenza allows following entities to bill medicare on his behalf.
Entity NameMayo Clinic
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1922074434
PECOS PAC ID: 6507778255
Enrollment ID: O20031103000285

News Archive

Experimental drug for rare ALS shows promise in early clinical trial

An experimental drug for a rare, inherited form of amyotrophic lateral sclerosis (ALS) has shown promise in a phase 1/phase 2 clinical trial conducted at Washington University School of Medicine in St. Louis, Massachusetts General Hospital in Boston and other sites around the world and sponsored by the pharmaceutical company Biogen Inc.

Evolution of the SARS-CoV-2 proteome in 3D during the first six months of the COVID-19 pandemic

In a recent study, researchers report how the SARS-CoV-2 proteome in 3D has evolved during the first six months of the COVID-19 pandemic.

Drowning deaths rise in Australia

The Royal Life Saving Society, Australia is alarmed at the rise in drownings in waterways around the country. With 314 people dying in a year the figures are at a seven year high. 80% of these were males. The Society noted a 27% rise in the numbers since 2002.

Social stress linked to visceral fat, atherosclerosis

A new study done by researchers at Wake Forest University School of Medicine shows that social stress could be an important precursor to heart disease by causing the body to deposit more fat in the abdominal cavity, speeding the harmful buildup of plaque in blood vessels, a stepping stone to the number one cause of death in the world.

Chromatrap® kit shown to excel in DNA purification

Chromatrap® reports on the excellent results achieved by customers using their 96 well high throughput plates for ultra-pure DNA purification.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Fernando C Fervenza is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Fernando C Fervenza, MD
200 1st St Sw,
Rochester, MN 55905-0001

Ph: (507) 284-2511
Fernando C Fervenza, MD
200 1st St Sw,
Rochester, MN 55905-0001

Ph: (507) 284-2511

News Archive

Experimental drug for rare ALS shows promise in early clinical trial

An experimental drug for a rare, inherited form of amyotrophic lateral sclerosis (ALS) has shown promise in a phase 1/phase 2 clinical trial conducted at Washington University School of Medicine in St. Louis, Massachusetts General Hospital in Boston and other sites around the world and sponsored by the pharmaceutical company Biogen Inc.

Evolution of the SARS-CoV-2 proteome in 3D during the first six months of the COVID-19 pandemic

In a recent study, researchers report how the SARS-CoV-2 proteome in 3D has evolved during the first six months of the COVID-19 pandemic.

Drowning deaths rise in Australia

The Royal Life Saving Society, Australia is alarmed at the rise in drownings in waterways around the country. With 314 people dying in a year the figures are at a seven year high. 80% of these were males. The Society noted a 27% rise in the numbers since 2002.

Social stress linked to visceral fat, atherosclerosis

A new study done by researchers at Wake Forest University School of Medicine shows that social stress could be an important precursor to heart disease by causing the body to deposit more fat in the abdominal cavity, speeding the harmful buildup of plaque in blood vessels, a stepping stone to the number one cause of death in the world.

Chromatrap® kit shown to excel in DNA purification

Chromatrap® reports on the excellent results achieved by customers using their 96 well high throughput plates for ultra-pure DNA purification.

Read more News

› Verified 6 days ago


Internal Medicine Doctors in Rochester, MN

Emily Leasure, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 200 1st St Sw, Rochester, MN 55905
Phone: 507-284-2511    
Jorge A Velosa, MD
Nephrology
Medicare: Not Enrolled in Medicare
Practice Location: 200 1st St Sw, Rochester, MN 55905
Phone: 507-284-2511    
Michael Ruediger Mueller,
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 200 1st St Sw, Rochester, MN 55905
Phone: 507-284-2511    
Mr. Karun Singh Badwal, D.O.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 200 1st St Sw, Rochester, MN 55905
Phone: 507-284-2511    
Michal Reid, M.D.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 200 1st St Sw, Rochester, MN 55905
Phone: 507-284-2511    
Katherine Desprez Wick, MD
Nephrology
Medicare: Medicare Enrolled
Practice Location: 200 1st St Sw, Rochester, MN 55905
Phone: 507-284-2511    
Dr. Allison Bock, M.D.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 200 1st St Sw, Rochester, MN 55905
Phone: 507-284-2511    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.